Epilepsy Market 2019 Industry Size, Key Highlights, Growth Analysis, Clinical Therapeutics, Competitive Share, Regional Scope and Forecast To 2023 The anti-epilepsy drugs market is likely to expand at a steady pace across the globe. Market Research Future stated in its recently published reports that the worldwide anti-epilepsy drugs market is growing and can be estimated to gain momentum during 2017 to 2022. The market has been anticipated to reflect a consistent upsurge by the conclusion of 2022, surpassing its earlier growth records in terms of worth with a remarkable CAGR over the forecast period. Global Epilepsy Market Key Players The global anti-epilepsy drugs market has been dominated by key players such as Johnson & Johnson, Pfizer, Inc., Abbott, UCB Pharma Ltd., GlaxoSmithKline plc, Sanofi, Novartis AG, Cephalon Inc., and Shire Pharmaceuticals Limited. These are some of the noteworthy players at the forefront of rivalry in the global anti-epilepsy dru...